These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8239479)

  • 61. Improved method for euglobulin clot lysis time.
    Lowe ML; Cannon DC
    Clin Biochem; 1975 Jun; 8(3):206-12. PubMed ID: 1149219
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The technique of quantitative determination of streptokinase in the patient's plasma (author's transl)].
    Auel H; Martin M
    Klin Wochenschr; 1975 Sep; 53(17):809-14. PubMed ID: 811926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fibrinolytic activity after administration of diflunisal and aspirin. A double-blind, randomized, placebo-controlled clinical trial.
    Green D; Davies RO; Holmes GI; Johnson C; Kohl H; Reynolds N; Ts'ao C
    Haemostasis; 1983; 13(6):394-8. PubMed ID: 6365701
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fibrinolytic activity of salivary euglobulin fractions precipitated at pH 5.9 or 6.4 before and after mixing with blood.
    Gersel-Pedersen N
    Int J Oral Surg; 1980 Jun; 9(3):190-7. PubMed ID: 6777318
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Natural history of autologous blood clot embolization in swine.
    Osterman FA; Bell WR; Montali RJ; Novak GR; White RI
    Invest Radiol; 1976; 11(4):267-76. PubMed ID: 134002
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fibrinolytic behavior in long-standing branch retinal vein occlusion.
    Patrassi GM; Mares M; Piermarocchi S; Santarossa A; Viero M; Girolami A
    Ophthalmic Res; 1987; 19(4):221-5. PubMed ID: 3696697
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Shortened method for the determination of euglobulin lysis time employing Malayan pit viper venom.
    Starr T; Gertler MM
    Thromb Res; 1989 Jun; 54(5):511-7. PubMed ID: 2772869
    [No Abstract]   [Full Text] [Related]  

  • 68. Amounts of tPA and PAI-1 in the euglobulin fraction obtained at different pH: their relation to the euglobulin clot lysis time.
    Urano T; Nishikawa T; Nagai N; Takada Y; Takada A
    Thromb Res; 1997 Oct; 88(1):75-80. PubMed ID: 9336876
    [No Abstract]   [Full Text] [Related]  

  • 69. Fibrinolysis, fibrinogen and trhombin time in newborns.
    Hrodek O; Mydlil V; Housková J; Velisková V
    Biol Neonate; 1976; 28(1-2):106-12. PubMed ID: 1247630
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The euglobulin lysis time: a method for evaluating the plasma fibrinolytic activity of normal and arthritic rats and the therapeutic value of antiinflammatory (steroidal and non-steroidal) agents.
    Rüegg M; Riesterer L; Jaques R
    Pharmacology; 1970; 4(4):242-54. PubMed ID: 5489998
    [No Abstract]   [Full Text] [Related]  

  • 71. Measurement of euglobulin fibrinolysis time in women with retarded fetal development. The effect of the clamping and step tests on plasminogen activator activity.
    Uszyński M; Majczyńska W; Koźmińska T
    Eur J Obstet Gynecol Reprod Biol; 1980 Dec; 11(3):147-55. PubMed ID: 7194806
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen.
    Chakrabarti R; Hocking ED; Fearnley GR
    J Clin Pathol; 1969 Nov; 22(6):659-62. PubMed ID: 5365337
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fibrinolysis during liver transplantation: analysis by the Thrombodynamics method.
    Roullet S; Labrouche S; Freyburger G
    J Clin Pathol; 2019 Sep; 72(9):636-638. PubMed ID: 30975704
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methodological study and a recommended technique for determining the euglobulin lysis time.
    Chakrabarti R; Bielawiec M; Evans JF; Fearnley GR
    J Clin Pathol; 1968 Nov; 21(6):698-701. PubMed ID: 5717541
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New instrument for automatic recording of clot lysis.
    Wilkens HJ; Back N
    Am J Clin Pathol; 1976 Jul; 66(1):124-31. PubMed ID: 132864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus.
    Sharma SC
    J Clin Pathol; 1981 May; 34(5):501-3. PubMed ID: 7053039
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In-vitro study of homocysteine and aspirin effects on fibrinolysis: measuring fibrinolysis parameters.
    Zavar-Reza J; Pouya FD; Jalali BA; Gholami F; Pouya ND
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):1-5. PubMed ID: 24374649
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced fibrinolytic potential in patients with arterial occlusive disease (AOD) in comparison with normal subjects.
    Hartl D; Tiso E; Anderle K; Philapitsch A; Anger G
    Haemostasis; 1988; 18 Suppl 1():93-8. PubMed ID: 3350395
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of heparin; of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysis.
    Vinazzer H; Stemberger A; Haas S; Blümel G
    Thromb Res; 1982 Aug; 27(3):341-52. PubMed ID: 6923656
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The fibrinolytic effects of anaesthesia.
    Simpson PJ; Radford SG; Forster SJ; Cooper GM; Hughes AO
    Anaesthesia; 1982 Jan; 37(1):3-8. PubMed ID: 7081646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.